Exiqon A/S Release: Interim Report for the Period of 1 January - 30 September 2012 (Unaudited)
10/30/2012 7:03:57 AM
More...
|
Exiqon A/S and Takara Bio Partner on the Distribution of miRCURY LNA™ Products in Asia
10/17/2012 9:54:37 AM
More...
|
Changes to Exiqon A/S’s Financial Calendar 2012
10/12/2012 9:37:26 AM
More...
|
Exiqon A/S Offers Unique Bioinformatics Tool for Design and Selection of LNA(TM) Enhanced qPCR Assays for Combined Analysis of Messenger RNA, MicroRNA and Other ncRNA
6/14/2012 10:02:54 AM
More...
|
Exiqon A/S Reports Full Year Results for 2011
2/23/2012 9:22:22 AM
More...
|
Exiqon A/S Launches New Products for the Research and Development of LNA(TM) Based Drugs
10/10/2011 1:43:28 PM
More...
|
Exiqon A/S Introduces Serum/Plasma and Cancer microRNA qPCR Arrays
8/31/2011 10:01:10 AM
More...
|
Exiqon A/S. LEO Pharma Bispebjerg Hospital, Gentofte Hospital, Copenhagen University Hospital and University of Copenhagen Publish Validation of Biomarkers for Patients With Chronic Skin Diseases
8/24/2011 10:00:06 AM
More...
|
Exiqon A/S Releases New Software for Advanced Data Analysis of qPCR microRNA Data
6/21/2011 10:30:47 AM
More...
|
Exiqon A/S Licenses Locked Nucleic Acids to IDEXX Laboratories, Inc. (IDXX) for Veterinary Diagnostics
6/20/2011 9:57:27 AM
More...
|
|